Track Encompass Health's EBIT ($920M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
Encompass Health (EHC) currently reports a EBIT of $920M as of June 2026. That compares with $950M in the prior-year period — down 3.1% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Encompass Health's EBIT history and peer comparisons.
Encompass Health's EBIT decreased from $950M to $920M — a 3.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Encompass Health's EBIT of $920M is lower than the Healthcare sector average of $22B. That is roughly 95.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Encompass Health reported $920M in EBIT as of June 2026. That compares with $950M in the prior-year period — down 3.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $920M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Encompass Health, and consider following EHC for alerts when major investors trade the stock.